No Data
No Data
ACESO LIFE SCI: Interim Report 2024/25
Aceso Life Sci (00474.HK): Jiang Yang appointed as a non-executive director.
Gelonghui December 3rd | aceso life sci (00474.HK) announced that Jiang Yang has been appointed as a non-executive director of the company, effective from December 3, 2024.
Aceso Life Science's Fiscal H1 Loss Narrows
a certain life sciences company (00474.HK) recorded a mid-term loss of approximately 0.195 billion Hong Kong dollars.
11月28日格隆汇丨aceso life sci (00474.HK) announced that as of September 30, 2024, for the six months ended, the total revenue of the company was approximately 109 million Hong Kong dollars (2023: approximately 113 million Hong Kong dollars). During the period, the group incurred a loss of approximately 195 million Hong Kong dollars (2023: 250 million Hong Kong dollars).
ACESO LIFE SCI: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
Aceso life sci (00474.HK) held a board of directors meeting on November 28 to approve the interim results.
Gelonghui, November 18 – aceso life sci (00474.HK) announced that the board of directors meeting will be held on November 28, 2024 (Thursday) at 12:00 noon at Room 2501-2509, 25/F, 瑞安 Center, 6-8 Harbour Road, Wan Chai, Hong Kong, to (including) approve the company's and its subsidiaries' unaudited interim results for the six months ended September 30, 2024 and its publication, as well as to consider the distribution of a mid-term dividend (if any).